Mannkind Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Mannkind Corporation

MNKD 5.590

+0.7%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	5/19/2022 12:23:18 PM
	of 84

MannKind Corp. said Tuesday it is buying the V-Go insulin delivery device from Zealand Pharma A/S for $10 million, with additional sales-based milestones plus the cost of certain inventory. Certain inventory and employees also are included under the terms of the agreement. V-Go is a once-daily, wearable, insulin delivery device that helps provide blood sugar control for everyday lifestyles. V-Go is worn like a patch and eliminates the need for taking multiple daily shots. The acquisition of V-Go by MannKind is anticipated to close in May. Write to Chris Wack at chris.wack@wsj.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next